🔴 Fennec Pharmaceuticals is trading 5% down today with no clear company-specific catalyst

Fennec Pharmaceuticals is trading at $9.97 (-5.05%) with no clear company-specific catalyst identified for the downward move.

• Recent corporate developments, including ASCO-related announcements and older investor updates, do not align with the timing of today's price action.
• The decline appears more likely driven by broader market risk sentiment or stock-specific trading pressure rather than a fresh fundamental event.